X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/03/2856586/0/en/ObsEva-Announces-Delisting-from-SIX-Swiss-Exchange-and-Exemption-from-Certain-Obligations-Associated-with-the-Maintenance-of-Listin.html
https://www.globenewswire.com/news-release/2024/03/19/2848274/0/en/ObsEva-Announces-Update-on-Board-of-Directors.html
https://www.fiercebiotech.com/biotech/obseva-winds-down-and-lays-all-staff-money-options-run-out
https://www.globenewswire.com//news-release/2024/02/28/2836594/0/en/ObsEva-Announces-Wind-Down-of-Operations-and-Notifies-SIX-that-it-Will-Lack-the-Resources-to-Establish-Audited-IFRS-Financial-Statements-for-2023.html
https://www.globenewswire.com/news-release/2024/01/31/2820701/0/en/Geneva-Court-Grants-Temporary-Moratorium-to-ObsEva.html
https://www.globenewswire.com//news-release/2023/11/30/2788224/0/en/ObsEva-Announces-Application-for-a-Moratorium-to-Facilitate-Pivotal-Deals.html
https://www.globenewswire.com/news-release/2023/09/27/2750031/0/en/ObsEva-Files-half-Year-2023-Financial-Statements.html
https://www.fiercebiotech.com/biotech/obseva-regains-china-rights-pregnancy-drug-after-partner-misses-deadlines
https://www.globenewswire.com/news-release/2023/07/13/2704038/0/en/ObsEva-Recovers-Full-Worldwide-Rights-on-Nolasiban.html
https://www.globenewswire.com/news-release/2023/06/30/2697507/0/en/ObsEva-SA-Announces-that-Shareholders-Approved-all-Board-Proposals-at-its-2023-Annual-General-Meeting-held-on-June-29-2023.html
Market Place
Share 
